Christophe Le Corre

Christophe Le Corre

Johnson & Johnson Co. - New Jersey / United States
Natural Sciences / Mathematical Sciences
AD Scientific Index ID: 4459172
-
person_outline Christophe Le Corre's MOST POPULAR ARTICLES
1-) Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study Journal of Clinical Oncology 30 (18), 2197-2203, 2012
2-) Final analysis: Phase II study of oral panobinostat in relapsed/refractory Hodgkin lymphoma patients following autologous hematopoietic stem cell transplant Blood 116 (21), 419, 2010
3-) Efficacy of panobinostat in phase II study in patients with relapsed/refractory Hodgkin lymphoma (HL) after high-dose chemotherapy with autologous stem cell transplant. Blood 114 (22), 923, 2009
4-) Inhibition of lysine acetyltransferase KAT6 in ER+HER2− metastatic breast cancer: a phase 1 trial Nature medicine 30 (8), 2242-2250, 2024
5-) Inhibition of lysine acetyltransferase KAT6 in ER+HER2− metastatic breast cancer: a phase 1 trial Nature medicine 30 (8), 2242-2250, 2024